Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits

Giuliano Tocci, Barbara Citoni, Vivianne Presta, Giovanna Leoncini, Francesca Viazzi, Barbara Bonino, Massimo Volpe, Roberto Pontremoli

Research output: Contribution to journalReview article

Abstract

Chronic kidney disease is a worldwide health problem often burdened by severe cardiovascular complications. Hypertension represents one of the most important risk factor in affecting cardiovascular profile of chronic kidney disease patients. Since renin-angiotensin-aldosterone system plays a major role in determining cardiovascular outcome, guidelines recommend the use of renin-angiotensin-aldosteron inhibitors in order to control hypertension.

Original languageEnglish
JournalInternal and Emergency Medicine
DOIs
Publication statusAccepted/In press - Jan 1 2019

Keywords

  • Cardiovascular risk
  • Hypertension
  • Renin-angiotensin-aldosterone

ASJC Scopus subject areas

  • Internal Medicine
  • Emergency Medicine

Fingerprint Dive into the research topics of 'Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits'. Together they form a unique fingerprint.

  • Cite this